功能化自组装多肽水凝胶与神经干细胞生物相容性研究
摘要
目的：获得均一性的神经干细胞方法：取新生1天内乳鼠的大脑皮层,机械分离出神经干细胞,无血清培养液培养,倒置相差显微镜观察干细胞的生长情况,Nestin免疫荧光法对神经干细胞进行鉴定结果：分离培养出的细胞聚集成神经球,呈悬浮状,可在体外大量增殖和长期存活。Nestin染色呈阳性结论：体外成功地分离及培养了大鼠NSCs
目的：设计与合成功能化自组装多肽水凝胶方法：采用固相法合成多肽RADA16与RADA16-IKVAV,将两者混合制备功能化自组装多肽水凝胶IKVAVmx。原子力显微镜观察其形态学特征结果：IKVAVmx可自组装形成水凝胶,原子力显微镜证实其由纳米纤维交织而成结论：成功地合成了IKVAVmx自组装多肽水凝胶
目的：检测功能化自组装多肽水凝胶体外与神经干细胞的生物相容性方法：采用无血清培养法从新生大鼠皮层分离培养NSCs。将NSCs分别接种到功能化自组装多肽水凝胶IKVAVmx(实验组)与自组装多肽水凝胶RADA16(对照组)表面。用CCK-8法检测细胞在两种水凝胶中的增殖能力。倒置显微镜观察细胞在两种水凝胶中的形态。激光扫描共聚焦显微镜观察细胞迁移情况。应用Nestin、MAP2、GFAP和CC-1免疫荧光染色,检测神经干细胞分化情况。Western blot检测两种水凝胶中NSCs的MAP2蛋白表达情况。结果：实验组中NSCs的增殖及迁移能力均明显高于对照组(P<0.05)；实验组中MAP2阳性细胞百分率较对照组显著提高(P<0.05),GFAP阳性细胞百分率较对照组显著降低(P<0.05)。实验组中MAP2的蛋白表达含量明显高于对照组(P<0.05)。结论：功能化自组装多肽水凝胶具有良好的细胞生物相容性,从而为神经组织工程提供了一个有前景的生物材料。
Objective:To culture rat neural stem cells (NSCs) the in vitro. Methods:NSCs harvested from the cerebral cortex of neonatal one-day rats were triturated and cultivated in serum-free medium. The morphology of growth of cells was demonstrated by inverted phase contrast microscopy. Immunofluorescence staining with Nestin was used to identify NSCs. Result:The cells isolated and cultured grew in a manner of neurospheres and suspended in the medium. The cells were capable of proliferating and maintaining long-term survival in vitro. Conclusion:NSCs derived from cerebral cortex of neonatal rats were successfully isolated and cultured in vitro.
Objective:To design and synthesize a new self-assembling peptide hydrogel scaffold.
Methods:Peptide RADA16 and RADA16-IKVAV were synthesized by solid phase method. The functionalized self-assembling peptide named IKVAVmx was then made by mixing the above two peptide solutions. The morphological features of IKVAVmx were studied by atom force microscope (AFM). Result:IKVAVmx could self-assemble to form a hydrogel. AFM showed that self-assembly hydrogel was made up of interconnected nanofibers.
Conclusion:IKVAVmx peptide was synthesized and could self-assemble into hydrogel.
Objective:To observe the of functionalized self-assembling peptide hydrogel with neural stem cells in vitro. Methods:NSCs were isolated from the cerebral cortex of neonatal rats and cultured in serum-free medium. NSCs were seeded on the surface of both the functionalized self-assembling peptide hydrogel (experimental group) and RADA16 self-assembling peptide hydrogel (control group). The proliferation behavior of the cells was evaluated by CCK-8 assay. The cell migration was detected by laser scan confocal microscope. Immunofluorescence staining with Nestin, MAP2, GFAP, and CC-1 was used to assess the differentiation of NSCs. The protein expression of MAP2 was determined by Western blot analysis. Result:The power of cell proliferation and migration in experimental group was significantly higher than that of control group (P<0.05). Compared with control group, the percentage of MAP2 positive cells increased significantly (P<0.05) and the percentage of GFAP positive cells decreased significantly (P<0.05) in experimental group. Western blot analysis indicated that MAP2 activity in IKVAVmx scaffold was significantly higher than that in pure RADA16 scaffold (P<0.05). Conclusion:The functionalized self-assembling peptide hydrogel has good biocompatibility with NSCs, suggesting that it may be a promising biomaterial for neural tissue engineering.
目的：设计与合成功能化自组装多肽水凝胶方法：采用固相法合成多肽RADA16与RADA16-IKVAV,将两者混合制备功能化自组装多肽水凝胶IKVAVmx。原子力显微镜观察其形态学特征结果：IKVAVmx可自组装形成水凝胶,原子力显微镜证实其由纳米纤维交织而成结论：成功地合成了IKVAVmx自组装多肽水凝胶
目的：检测功能化自组装多肽水凝胶体外与神经干细胞的生物相容性方法：采用无血清培养法从新生大鼠皮层分离培养NSCs。将NSCs分别接种到功能化自组装多肽水凝胶IKVAVmx(实验组)与自组装多肽水凝胶RADA16(对照组)表面。用CCK-8法检测细胞在两种水凝胶中的增殖能力。倒置显微镜观察细胞在两种水凝胶中的形态。激光扫描共聚焦显微镜观察细胞迁移情况。应用Nestin、MAP2、GFAP和CC-1免疫荧光染色,检测神经干细胞分化情况。Western blot检测两种水凝胶中NSCs的MAP2蛋白表达情况。结果：实验组中NSCs的增殖及迁移能力均明显高于对照组(P<0.05)；实验组中MAP2阳性细胞百分率较对照组显著提高(P<0.05),GFAP阳性细胞百分率较对照组显著降低(P<0.05)。实验组中MAP2的蛋白表达含量明显高于对照组(P<0.05)。结论：功能化自组装多肽水凝胶具有良好的细胞生物相容性,从而为神经组织工程提供了一个有前景的生物材料。
Objective:To culture rat neural stem cells (NSCs) the in vitro. Methods:NSCs harvested from the cerebral cortex of neonatal one-day rats were triturated and cultivated in serum-free medium. The morphology of growth of cells was demonstrated by inverted phase contrast microscopy. Immunofluorescence staining with Nestin was used to identify NSCs. Result:The cells isolated and cultured grew in a manner of neurospheres and suspended in the medium. The cells were capable of proliferating and maintaining long-term survival in vitro. Conclusion:NSCs derived from cerebral cortex of neonatal rats were successfully isolated and cultured in vitro.
Objective:To design and synthesize a new self-assembling peptide hydrogel scaffold.
Methods:Peptide RADA16 and RADA16-IKVAV were synthesized by solid phase method. The functionalized self-assembling peptide named IKVAVmx was then made by mixing the above two peptide solutions. The morphological features of IKVAVmx were studied by atom force microscope (AFM). Result:IKVAVmx could self-assemble to form a hydrogel. AFM showed that self-assembly hydrogel was made up of interconnected nanofibers.
Conclusion:IKVAVmx peptide was synthesized and could self-assemble into hydrogel.
Objective:To observe the of functionalized self-assembling peptide hydrogel with neural stem cells in vitro. Methods:NSCs were isolated from the cerebral cortex of neonatal rats and cultured in serum-free medium. NSCs were seeded on the surface of both the functionalized self-assembling peptide hydrogel (experimental group) and RADA16 self-assembling peptide hydrogel (control group). The proliferation behavior of the cells was evaluated by CCK-8 assay. The cell migration was detected by laser scan confocal microscope. Immunofluorescence staining with Nestin, MAP2, GFAP, and CC-1 was used to assess the differentiation of NSCs. The protein expression of MAP2 was determined by Western blot analysis. Result:The power of cell proliferation and migration in experimental group was significantly higher than that of control group (P<0.05). Compared with control group, the percentage of MAP2 positive cells increased significantly (P<0.05) and the percentage of GFAP positive cells decreased significantly (P<0.05) in experimental group. Western blot analysis indicated that MAP2 activity in IKVAVmx scaffold was significantly higher than that in pure RADA16 scaffold (P<0.05). Conclusion:The functionalized self-assembling peptide hydrogel has good biocompatibility with NSCs, suggesting that it may be a promising biomaterial for neural tissue engineering.
引文
1. Schwab ME. Repairing the injured spinal cord. Science,2002; 295:1029-1031.
2. Kwon BK, Fisher CG, Dvorak M F, et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine,2005; 30:3-13.
3. Fehlings MG, Baptiste DC. Current status of clinical trials for acute spinal cord injury. Injury,2005; 36:113-122.
4. Schmidt CE. Leach JB. Neural tissue engineering:strategies for repair and regeneration. Annu Rev Biomed Eng,2003; 5:293-341.
5. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
6. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
7. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
8. Gage FH. Mammalian neural stem cell. Science,2000; 287:1433-1438.
9. Heller DA, Garga V, Kelleher KJ, et al. Patterned networks of mouse hippocampal neurons on peptide-coated gold surfaces. Biomaterials,2005; 26:883-889.
10. Shaw D, Shoichet MS. Toward spinal cord injury repair strategies:peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J Craniofac Surg,2003; 14:308-316.
11. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science,2004,303:1352-1355
1. Kwon BK, Fisher CG, Dvorak M F, et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine,2005; 30:3-13.
2. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science,1992; 255:1707-1710.
3. Davis AA, Temple S. A self-renewing multipotential stem cells in embryonic rat cerebral cortex. Nature,1994; 372:263-266
4. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci,1997; 17(3):5046-5061.
5. Kallos MS, Behie LA, Vescovi AL. Extended serial passaging of mammalian neural stem cells in suspension bioreactors. Biotechnol Bioeng,1999,65:589-99.
6. Vescovi AL, Parati EA, Gritti A, et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transp lantable human neural stem cell lines by epigenetic stimulation. Exp Neurol,1999; 156:71-83.
7. Temple S. The development of neural stem cells. Nature,2001; 414:112-117.
8. Whittemore SR, Morassutti DJ, Waiters WM, et al. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp Cell Res,1999; 252:75-95.
9. Brent A, Samuel W. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science,1992; 255:1707-1710.
10. Qian X, Davis AA, Goderie SK et al. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron,1997; 18:81-93.
11. Ciccolini F Identification of two distinct types of multipotent neural precursors that appear sequentially during CNS development. Mol Cell Neuro,2001; 17:895-907.
12. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell,1990; 60:585-595.
13. Cheng L, Jin Z, Liu L, et al. Characterization and promoter analysis of t he mouse nestin gene. FEBS Lett,2004; 565:195-202.
14. Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organization. Histol Histopathol,2005; 20:665-671.
15. Cai J, Wu Y, Mirua T, et al. Properties of a fetal multipotent neural stem cell (NEP cell). Dev Biol,2002; 251:221-240.
1. Whitesides GM, Mathias JP, Seto CT. Molecular self-assembly and nanochemistry:a chemical strategy for the synthesis of nanostructures. Science,1991; 254:1312-1319.
2. Corinne LD. Estimating the Efficiency of Self-Assemblies. Journal of Supramolecular Chemistry,2001; 1:39-52.
3. Whitesides GM, Mathias JP, Seto CT. Molecular self-assembly and nanochemistry:a chemical strategy for the synthesis of nanostructures. Science,1991; 254:1312-1319.
4. Ghadiri MR, Granja JR, Milligan RA, et al. Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature,1993; 366:324-327.
5. Zhang S, Holmes T, Lockshin C, et al. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA,1993; 90:3334-3338.
6. Giorgio C, Patricia S, Ehud G. Peptide self-assembly at the nanoscale:a challenging target for computational and experimental biotechnology. Trends Biochem Sci,2007; 25:211-218.
7. Aggeli A, Bell M, Carrick LM, et al. pH as a trigger of peptide β-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc,2003; 125:9619-9628.
8. Kirkham J, Firth A, Vernals D, et al. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res,2007; 86:426-430.
9. Firth A, Aggeli A, Burke JL, et al. Biomimetic self-assembling peptides as injectable scaffolds for hard tissue engineering. Nanomed,2006; 1:189-199.
10. Bell CJ, Carrick LM, Katta J, et al. Self-assembling peptides as injectable lubricants for osteoarthritis. J Biomed Mater Res A,2006; 78:236-246.
11. Aggeli A, Bell M, Boden N, et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric (3-sheet tapes. Nature,1997; 386:259-262.
12. Aggeli A, Nyrkova IA, Bell M, et al. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide (3-sheet tapes, ribbons, fibrils, and fibres. Proc Natl Acad Sci USA,2001; 98:11857-11862.
13. Kretsinger JK, Haines LA, Ozbas B, et al. Cytocompatibility of self-assembled β-hairpin peptide hydrogel surfaces. Biomaterials,2005; 26:5177-5186.
14. Moutevelis E, Woolfson DN. A periodic table of coiled-coil protein structures. J Mol Biol,2009; 385:726-732.
15. Bromley EH, Sessions RB, Thomson AR, et al. Designed a-helical tectons for constructing multicomponent synthetic biological systems. J Am Chem Soc,2009; 131:928-930.
16. Papapostolou D, Smith AM, Atkins ED, et al. Engineering nanoscale order into a designed protein fiber. Proc Natl Acad Sci USA,2007; 104:10853-10858.
17. Gribbon C, Channon KJ, Zhang W, et al. Magic Wand:a single, designed peptide that assembles to stable, ordered a-helical fibers. Biochemistry,2008; 47:10365-10371.
18. Dong H, Paramonov SE, Hartgerink JD. Self-assembly of a-helical coil-coiled nanofibers. J Am Chem Soc,2008; 130:13691-13695.
19. Kotch FW, Raines RT. Self-assembly of synthetic collagen triple helices. Proc Natl Acad Sci, USA.2006; 103:3028-3033.
20. Holmes TC. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol,2002; 20:16-21.
21. Branden C, Tooze J. Introduction to protein structure.2nd ed. New York, NY:Garland Publishing; 1999.
22. Petsko GA, Ringe D. Protein structure and function. London, UK:New Science Press Ltd.; 2003.
23. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
24. Davis ME, Motion JP. Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 2005; 111:442-450.
25. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
26. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
27. Yokoi H, Kinoshita T, Zhang S. Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc Natl Acad Sci USA,2005; 102:8414-8419.
28. Genove E, Shen C, Zhang S, et al. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials,2005:26:3341-3351.
1. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
2. Davis ME, Motion JP, Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 2005; 111:442-450.
3. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
4. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
5. Caplan MR, Schwartzfarb EM, Zhang S, et al. Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. Biomaterials, 2002; 23:219-227.
6. Genove E, Shen C, Zhang S, et al. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials,2005; 26:3341-3351.
7. Heller DA, Garga V, Kelleher KJ, et al. Patterned networks of mouse hippocampal neurons on peptide-coated gold surfaces. Biomaterials,2005; 26:883-889.
8. Shaw D, Shoichet MS. Toward spinal cord injury repair strategies:peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J Craniofac Surg,2003; 14:308-316.
9. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science,2004; 303:1352-1355.
10. Gage FH. Mammalian neural stem cell. Science,2000; 287:1433-1438.
11. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Experimental neurology,2001; 167:48-58.
12. Cao QL, Howard RM, Dennison JB, et al. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Experimental neurology,2002; 177:349-359.
13. Enzmann GU, Benton RL, Woock JP, et al. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Experimental neurology,2005; 195:293-304.
14. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Experimental neurology,2004; 189:33-44.
15. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental neurology,2003; 181:115-129.
16. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. Journal of neuroscience research,2006; 84:1669-1681.
17. Pfeifer K, Vroemen M, Blesch A, et-al. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. The European journal of neuroscience,2004; 20:1695-1704.
18. Vroemen M, Aigner L, Winkler J, et al. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. The European journal of neuroscience,2003; 18:743-751.
19. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America, 2006; 103:13174-13179.
20. Engesser-Cesar C, Anderson AJ, Basso DM, et al. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma,2005; 22:157-171.
21. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proceedings of the National Academy of Sciences of the United States of America,2005; 102:14069-14074.
22. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cell differentiation following transplantation into spinal cord injured mice:association with recovery of locomotor function. Neurol Res,2006; 28:474-481.
23. Wu P, Tarasenko YI, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nature neuroscience,2002; 5:1271-1278.
24. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. Journal of neuroscience research,2005; 80:182-190.
25. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. Journal of neuroscience research, 2007; 85:47-57.
26. Howard MJ, Gershon MD. Development of LBP110 expression by neural crest-derived enteric precursors:migration and differentiation potential in Is/Is mutant mice. J Neurobiol,1998; 35:341-354.
27. Chalazonitis A, Tennyson VM, Kibbey MC, et al. The alphal subunit of laminin-1 promotes the development of neurons by interacting with LBP110 expressed by neural crest-derived cells immunoselected from the fetal mouse gut. J Neurobiol,1997; 33:118-138.
1. National Spinal Cord Injury Statistical Center Fact Sheet. National Spinal Cord Injury Center, Jun.2006.
2. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull,1999; 49:377-391.
3. McGee AW, Strittmatter SM. The Nogo-66 receptor:focusing myelin inhibition of axon regeneration. Trends Neurosci,2003; 26:193-198.
4. Myckatyn TM, Mackinnon SE, McDonald JW. Stem cell transplantation and other novel techniques for promoting recovery from spinal cord injury. Transpl Immunol, 2004; 12:343-358.
5. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol,2007; 17:120-127.
6. Greitz D. Unraveling the riddle of syringomyelia. Neurosurgical review 2006; 29:251-263.
7. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Experimental neurology,2004; 187:266-278.
8. Wu S, Suzuki Y, Ejiri Y, et al. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. Journal of neuroscience research,2003; 72:343-351.
9. Fok-Seang J, Smith-Thomas LC, Meiners S et al. An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res,1995; 689:207-223.
10. Smith-Thomas LC, Stevens J, Fok-Seang J, Faissner A, Rogers JH, Fawcett JW. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci,1995; 108:1307-1315.
11. Jones LL, Sajed D, Tuszynski MH. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury:a balance of permissiveness and inhibition. J Neurosci 2003; 23:9276-9288.
12. Curinga GM, Snow DM, Mashburn C, et al. Mammalianproduced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J Neurochem.2007; 102:275-288.
13. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002; 417:941-944.
14. Kottis V, Thibault P, Mikol D, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002; 82:1566-1569.
15. Huber AB, Schwab ME. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biological chemistry 2000; 381:407-419.
16. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature,2000; 403:434-439.
17. Liu BP, Fournier A, GrandPre T, et al. Myelinassociated glycoprotein as a functional ligand for the Nogo-66 receptor. Science,2002; 297:1190-1193.
18. Li S, Kim JE, Budel S, Hampton TG, et al. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Molecular and cellular neurosciences,2005; 29:26-39.
19. Yang LJ, Lorenzini I, Vajn K, et al. Sialidase enhances spinal axon outgrowth in vivo. Proceedings of the National Academy of Sciences of the United States of America 2006; 103:11057-11062.
20. Apostolova I, Irintchev A, Schachner M. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci,2006; 26:7849-7859.
21. Becker CG, Becker T, Meyer RL, Schachner M. Tenascin-R inhibits the growth of optic fibers in vitro but is rapidly eliminated during nerve regeneration in the salamander Pleurodeles waltl. J Neurosci,1999; 19:813-827.
22. Willerth SM, Arendas KJ, Gottlieb DI, et al. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006; 27:5990-6003.
23. Levenberg S, Burdick JA, Kraehenbuehl T, et al. Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue engineering,2005; 11:506-512.
24. Levenberg S, Huang NF, Lavik E, et al Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proceedings of the National Academy of Sciences of the United States of America 2003; 100:12741-12746.
25. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2002; 99:3024-3029.
26. Nomura H, Tator CH, Shoichet MS. Bioengineered strategies for spinal cord repair. J Neurotrauma,2006; 23:496-507.
27. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12:1-21.
28. Elisseeff JH. Embryonic stem cells:potential for more impact. Trends in Biotechnology,2004; 22:155-156.
29. Polak JM, Bishop AE. Stem cells and tissue engineering:past, present, and future. Annals of the New York Academy of Sciences,2006; 1068:352-366.
30. Wobus AM, Holzhausen H, Jakel P, et al. Characterization of a pluripotent stem cell line derived from a mouse embryo. Experimental cell research,1984; 152:212-219.
31. Keirstead HS. Stem cell transplantation into the central nervous system and the control of differentiation. Journal of neuroscience research,2001; 63:233-236.
32. Lee H, Al Shamy G, Elkabetz Y, et al. Directed Differentiation And Transplantation of Human Embryonic Stem Cell Derived Motoneurons. Stem cells,2007; 25:1931-1939.
33. Bain G, Kitchens D, Yao M, et al. Embryonic stem cells express neuronal properties in vitro. Developmental biology,1995; 168:342-357.
34. Liu S, Qu Y, Stewart TJ, Howard MJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proceedings of the National Academy of Sciences of the United States of America, 2000; 97:6126-6131.
35. Brustle O, Jones KN, Learish RD, et al. New York, NY:1999. Embryonic stem cell-derived glial precursors:a source of myelinating transplants. Science,285: 754-756.
36. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature medicine,1999; 5:1410-1412.
37. Jendelova P, Herynek V, Urdzikova L, et al. Magneticresonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. Journal of neuroscience research 2004; 76:232-243.
38. Kitagawa A, Nakayama T, Takenaga M, et al. Lecithinized brainderived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo. Biochemical and biophysical research communications,2005; 328:1051-1057.
39. Hendricks WA, Pak ES, Owensby JP, et al. Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice. Molecular medicine,2006; 12:34-46.
40. Howard MJ, Liu S, Schottler F, et al. Transplantation of apoptosis-resistant embryonic stem cells into the injured rat spinal cord. Somatosensory & motor research,2005; 22:37-44.
41. Chen J, Bernreuther C, Dihne M, et al. Cell adhesion molecule 11-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma 2005,22:896-906.
42. Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia, 2005; 49:385-396.
43. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci,2005; 25:4694-4705.
44. Faulkner J, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol,2005; 15:131-142.
45. Cloutier F, Siegenthaler MM, Nistor G, et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regenerative medicine,2006; 1:469-479.
46. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Experimental neurology,2001; 167:48-58.
47. Cao QL, Howard RM, Dennison JB, et al. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Experimental neurology,2002; 177:349-359.
48. Enzmann GU, Benton RL, Woock JP, et al. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal a) cord. Experimental neurology,2005; 195:293-304.
49. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Experimental neurology,2004; 189:33-44.
50. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental neurology,2003; 181:115-129.
51. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. Journal of neuroscience research,2006; 84:1669-1681.
52. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America, 2006; 103:13174-13179.
53. Engesser-Cesar C, Anderson AJ, Basso DM, et al. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma,2005; 22:157-171.
54. Vroemen M, Aigner L, Winkler J, et al. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. The European journal of neuroscience,2003; 18:743-751.
55. Pfeifer K, Vroemen M, Blesch A, et-al. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. The European journal of neuroscience,2004; 20:1695-1704.
56. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proceedings of the National Academy of Sciences of the United States of America,2005; 102:14069-14074.
57. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cell differentiation following transplantation into spinal cord injured mice:association with recovery of locomotor function. Neurol Res,2006; 28:474-481.
58. Wu P, Tarasenko YI, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nature neuroscience,2002; 5:1271-1278.
59. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. Journal of neuroscience research,2005; 80:182-190.
60. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. Journal of neuroscience research, 2007; 85:47-57.
61. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of neuroscience research,2000; 61:364-370.
62. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental neurology,2000; 164:247-256.
63. Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochemical and biophysical research communications,2001; 282:148-152.
64. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences of the United States of America,2002; 99:2199-2204.
65. Bakshi A, Barshinger AL, Swanger SA, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion:a novel method for minimally invasive cell transplantation. J Neurotrauma,2006; 23:55-65.
66. Shi E, Kazui T, Jiang X, et al. Therapeutic benefit of intrathecal injection of marrow stromal cells on ischemia-injured spinal cord. The Annals of thoracic surgery,2007; 83:1484-1490.
67. Khalatbary AR, Tiraihi T. Localization of bone marrow stromal cells in injured spinal cord treated by intravenous route depends on the hemorrhagic lesions in traumatized spinal tissues. Neurol Res,2007; 29:21-26.
68. Vaquero J, Zurita M, Oya S, et al. Cell therapy using bone marrow stromal cells in chronic paraplegic rats:systemic or local administration? Neuroscience letters,2006; 398:129-134.
69. Zurita M, Vaquero J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats:functional and morphological outcome one year after transplantation. Neuroscience letters,2006; 402:51-56.
70. Himes BT, Neuhuber B, Coleman C, et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabilitation and neural repair,2006; 20:278-296.
71. Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Experimental neurology,2004; 190:17-31.
72. Yano S, Kuroda S, Shichinohe H, et al. Bone marrow stromal cell transplantation preserves gammaaminobutyric acid receptor function in the injured spinal cord. J Neurotrauma,2006; 23:1682-1692.
73. Isele NB, Lee HS, Landshamer S, et al. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochemistry international,2007; 50:243-250.
74. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Experimental neurology,2005; 191:344-360.
75. Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic spinal cord injury. Experimental neurology,2007; 203:8-21.
76. Pannucci C, Myckatyn TM, Mackinnon SE, et al. End-to-side nerve repair:Review of the literature. Restorative neurology and neuroscience,2007; 25:45-63.
77. Feron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain,2005; 128:2951-2960.
78. Current Protocols in Cell Biology. John Wiley & Sons; 1998.
79. Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma,2006; 23:453-467.
80. Beattie MS, Bresnahan JC, Komon J, et al. Endogenous repair after spinal cord contusion injuries in the rat. Experimental neurology,1997; 148:453-463.
81. Blakemore WF. Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature,1977; 266:68-69.
82. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science,1981; 214:931-933.
83. Xu XM, Guenard V, Kleitman N, et al. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. The Journal of comparative neurology,1995; 351:145-160.
84. Xu XM, Guenard V, Kleitman N, et al. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Experimental neurology,1995; 134:261-272.
85. Xu XM, Chen A, Guenard V, et al. Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. Journal of neurocytology,1997; 26:1-16.
86. Imaizumi T, Lankford KL, Kocsis JD. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res 2000; 854:70-78.
87. Pinzon A, Calancie B, Oudega M, et al. Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. Journal of neuroscience research,2001; 64:533-541.
88. Takami T, Oudega M, Bates ML, et al. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci,2002; 22:6670-6681.
89. Menei P, Montero-Menei C, Whittemore SR, et al. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. The European journal of neuroscience,1998; 10:607-621.
90. Tuszynski MH, Weidner N, McCormack M, et al. Grafts of genetically modified Schwann cells to the spinal cord:survival, axon growth, and myelination. Cell transplantation,1998; 7:187-196.
91. Hurtado A, Moon LD, Maquet V, et al. Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials,2006; 27:430-442.
92. Chau CH, Shum DK, Li H, et al. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. Faseb J,2004; 18:194-196.
93. Pearse DD, Pereira FC, Marcillo AE, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature medicine,2004; 10:610-616.
94. Ruitenberg MJ, Vukovic J, Sarich J, et al. Olfactory ensheathing cells:characteristics, genetic engineering, and therapeutic potential. J Neurotrauma,2006; 23:468-478.
95. Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science,1997; 277:2000-2002.
96. Li Y, Field PM, Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci,1998; 18:10514-10524.
97. Keyvan-Fouladi N, Raisman G, Li Y. Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci,2003; 23:9428-9434.
98. Ramon-Cueto A, Cordero MI, Santos-Benito FF, et al. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron,2000; 25:425-435.
99. Lu J, Feron F, Ho SM, et al. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res,2001; 889:344-357.
100.Garcia-Alias G, Lopez-Vales R, Fores J, et al. Acute transplantation of olfactoryensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. Journal ofneuroscience research,2004; 75:632-641.
101.Kato T, Honmou 0, Uede T, et al. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 2000; 30:209-218.
102.Verdu E, Garcia-Alias G, Fores J, et al. Olfactory ensheathing cells transplanted in lesioned spinal cord prevent loss of spinal cord parenchyma and promote functional recovery. Glia,2003; 42:275-286.
103.Plant GW, Christensen CL, Oudega M, et al. Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma,2003; 20:1-16.
104.Ruitenberg MJ, Plant GW, Hamers FP, et al. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia:effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci,2003; 23:7045-7058.
105.Ruitenberg MJ, Levison DB, Lee SV, et al. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain,2005; 128:839-853.
106.Cao L, Liu L, Chen ZY, et al. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain,2004; 127:535-549.
107.Grill R, Murai K, Blesch A, et al. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci,1997; 17:5560-5572.
108.Tuszynski MH, Grill R, Jones LL, et al. Spontaneous and augmented growth of axons in the primate spinal cord:effects of local injury and nerve growth factor-secreting cell grafts. The Journal of comparative neurology,2002; 449:88-101.
109.Tobias CA, Shumsky JS, Shibata M, et al. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Experimental neurology,2003; 184:97-113.
110.Shumsky JS, Tobias CA, Tumolo M, et al. Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Experimental neurology,2003; 184:114-130.
111.McTigue DM, Horner PJ, Stokes BT, et al. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci,1998; 18:5354-5365.
112.Blesch A, Tuszynski MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. The Journal of comparative neurology,2003; 467:403-417.
113.Blesch A, Yang H, Weidner N, et al. Axonal responses to cellularly delivered NT-4/5 after spinal cord injury. Molecular and cellular neurosciences,2004; 27:190-201.
114.Pizzi MA, Crowe MJ. Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats. J Neurotrauma,2006; 23:1750-1765.
115.Mahoney MJ, Anseth KS. Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials,2006; 27:2265-2274.
116.Mahoney MJ, Anseth KS. Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic PEG hydrogels. Journal of biomedical materials research,2007; 81:269-278.
117.Taylor SJ, McDonald JW 3rd, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release,2004; 98:281-294.
118.Taylor SJ, Rosenzweig ES, McDonald JW 3rd, et al. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release, 2006; 113:226-235.
119.Taylor SJ, Sakiyama-Elbert SE. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release,2006; 116:204-210.
120.Willerth SM, Faxel TE, Gottlieb DI, et al. The Effects of Soluble Growth Factors on Embryonic Stem Cell Differentiation Inside of Fibrin Scaffolds. Stem cells,2007; 25: 2235-2244.
121.Ma W, Fitzgerald W, Liu QY, et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Experimental neurology,2004; 190:276-288.
122.Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene therapy,2001; 8:954-960.
123.Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature,2007; 448:318-324.
124.Lowry NA, Temple S. Making human neurons from stem cells after spinal cord injury. PLoS medicine,2007; 4:e48.
1. Zhang S. Emerging biological materials through molecular self-assembly. Biotechnol Adv,2002; 20:321-339.
2. Mitraki A, van Raaij MJ. Folding of P-structured fibrous proteins and self-assembling peptides. Methods Mol Biol,2005; 300:125-140.
3. Kluge JA, Rabotyagova O, Leisk GG, et al. Spider silks and their applications. Trends Biotechnol,2008; 26:244-251.
4. Koster S, Evans HM, Wong JY, et al. An in situ study of collagen self-assembly processes. Biomacromolecules,2008; 9:199-207.
5. Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater,2008; 15:53-76.
6. Chen H, Clarkson BH, Sun K, et al. Self-assembly of synthetic hydroxyapatite nanorods into an enamel prism-like structure. J Colloid Interface Sci,2005; 288:97-103.
7. Merrifield RB. Solid phase peptide synthesis. Ⅰ. The synthesis of a tetrapeptide. J. Am Chem Soc,1963; 85:2149-2154.
8. Sato AK, Viswanathan M, Kent RB, et al. Therapeutic peptides:technological advances driving peptides into development. Curr Opin Biotechnol.2006; 17:638-642.
9. Morreale G, Lee EG, Jones DB, et al. Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide. Biotechnol. Bioeng,2004; 87:912-923.
10. Prockop DJ, Kivirikko KI. Collagens:molecular biology, diseases, and potentials for therapy. Annu Rev Biochem,1995; 64:403-434.
11. Gelse K, Poschl E, Aigner T, et al. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev,2003; 55:1531-1546.
12. Prockop DJ. Kivirikko KI, Tuderman L, et al. The biosynthesis of collagen and its disorders. N Engl J Med,1979; 301:13-23.
13. Miyahara M, Njieha FK, Prockop DJ et al. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen protineases. J Biol Chem,1982; 257:8442-8448.
14. Brodsky B. Collagens and gelatins. In:Fahnestock, SR.; Steinbiichel, A., editors. Biopolymers, Polyamide and Complex Proteinaceous Materials.2nd edn. Vol. Vol.8. Wiley-VCH; Verlag GmbH,2003. p.119-128.
15. Pachence JM. Collagen-based devices for soft tissue repair. J Biomed Mater Res,1996; 33:35-40.
16. Olsen D, Yang C, Bodo M, et al. Recombinant collagen and gelatine for drug delivery. Adv Drug Deliv, Rev.2003; 55:1547-1567.
17. Baez J. Olsen D, Polarek JW. Recombinant microbial systems for the production of human collagen and gelatine. Appl Microbiol Biotechnol,2005; 69:245-252.
18. Koide T, Watson R, Kind AJ, et al. Triple helical collagen-like peptides:engineering and applications in matrix biology. Connect Tissue Res,2005; 46:131-141.
19. John DC. Expression of an engineered form of recombinant procollagen in mouse milk. Nat Biotechnol,1999; 17:385-389.
20. Bulleid NJ. John DC, Kadler KE. Recombinant expression systems for the production of collagen. Biochem Soc Trans,2000; 28:350-353.
21. Majsterek I, McAdams E, Adachi E, et al. Prospects and limitations of the rational engineering of fibrillar collagens. Protein Sci,2003; 12:2063-2072.
22. Tomita M, Kitajima T, Yoshizato K. Formation of recombinant human procollagen I heterotrimers in a baculovirus expression system. J. Biochem.1997; 121:1061-1069.
23. Kitajima T, Terai H, Ito Y et al. A fusion protein of hepatocyte growth factor for immobilisation to collagen. Biomaterials,2007; 28:1989-1997.
24. Ruggiero F, Exposito JY, Bournat P, et al. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett,2000; 469:132-136.
25. Merle C, Perret S, Lacour T, et al. Hydroxylated human homotrimeric collagen I in Agrobacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett,2002; 515:114-118.
26. Stephan S, Sherratt MJ, Hodson N, et al. Expression and supramolecular assembly of recombinant al (Ⅷ) and a2 (Ⅷ) collagen homotrimers. J Biol Chem,2004; 279:21469-21477.
27. Pakkanen O, Hamalainen ER, Kivirikko KI, et al. Assembly of stable human type Ⅰ and Ⅲ collagen molecules from hydroxylated recombinant chains in the yeast Pichia pastoris. Effect of an engineered C-terminal oligomerization domain foldon. J Biol Chem,2003; 278:32478-32483.
28. Du C, Wang M, Liu J, et al. Improvement of thermostability of recombinant collagen-like protein by incorporating a foldon sequence. Appl. Microbiol. Biotechnol, 2008; 79:195-202.
29. Keeley FW. Elastin as a self-organising biomaterial:use of recombinantly expressed human elastin polypeptides as a model for investigations of structure and self-assembly of elastin. Philos Trans R Soc Lond B Biol Sci,2002; 357:185-189.
30. Bellingham CM, Woodhouse KA, Robson P, et al. Self-aggregation characteristics of recombinantly expressed human elastin polypeptides. Biochim Biophys Acta,2001; 1550:6-19.
31. Urry DW. Molecular machines:how motion and other functions of living organisms cans result from reversible chemical changes. Angew Chem Int Ed Engl,1993; 32:819-841.
32. Bellingham CM, Keeley FW. Self-ordered polymerisation of elastin-based biomaterials. Curr Opin Solid State Mater Sci,2004; 8:135-139.
33. Daamen WF. Hafmans T, Veerkamp JH et al. Comparison of five procedures for the purification of insoluble elastin. Biomaterials 2001; 22:1997-2005.
34. Daamen WF, Nillesen ST, Hafmans T, et al. Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 2005; 26:81-92.
35. Urry DW, Pattanaik A, Xu J, et al. Elastic protein-based polymers in soft tissue augmentation and generation. J Biomater Sci Polym Ed,1998; 9:1015-1048.
36. Betre H, Setton LA, Meyer DE, et al. Characterisation of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002; 3:910-916.
37. Ong SR, Trabbic-Carlson KA, Nettles DL, et al. Epitope tagging for tracking elastin-like polypeptides. Biomaterials,2006; 27:1930-1935.
38. Srokowski EM, Woodhouse KA. Development and characterization of novel cross-linked bioelastomeric materials. J Biomater Sci Polym Ed,2008; 19:785-799.
39. Nicol A, Gowda C, Urry DW et al. Elastic protein-based polymers as cell attachment matrices. J Vasc Surg,1991; 13:746-748.
40. Wagenseil JE, Mecham RP. New insights into elastic fibre assembly. Birth Defects Res C Embryo Today,2007; 81:229-240.
41. Li B, Daggett V. The molecular basis of the temperature and pH induced conformational transitions in elastin-based peptides. Biopolymers,2003; 68:121-129.
42. Urry DW. Characterisation of soluble peptides of elastin by physical techniques. Methods Enzymol,1982; 82:673-716.
43. Raucher D, Chilkoti A. Enahnced uptake of a thermally responsive polypeptide by tumour cells in response to its hyperthermia-mediated phase transition. Cancer Res, 2001; 61:7163-7170.
44. Li B, Alonso DO, Daggett V et al. The molecular basis for the inverse temperature transition of elastin. J Mol Biol,2001; 305:581-592.
45. Nicol A, Gowda DC, Urry DW et al. Cell adhesion and growth on synthetic elastomeric matrices containing Arg-Gly-Asp-Ser-3. J Biomed Mater Res,1992; 26:393-413.
46. McPherson DT, Morrow C, Minehan DS, et al. Production and purification of a recombinant elastomeric polypeptide, G-(VPGVG)19-VPGV, from Escherichia coli. Biotechnol Prog,1992:8:347-352.
47. McHale MK, Setton LA, Chilkoti A. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng, 2005; 11:1768-1779.
48. Woodhouse KA, Klement P, Chen V, et al. Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials,2004; 25:4543-4553.
49. Girotti A, Reguera J, Rodriguez-Cabello JC, et al. Design and bioproduction of a recombinant multi(bio)functional elastin-like protein polymer containing cell adhesion sequences for tissue engineering purposes. J Mater Sci Mater Med,2004; 15:479-484.
50. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high epitope density nanofibers. Science,2004; 303:1352-1355.
51. Gelain F, Bottai D, Vescovi A, et al. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS One 2006; 1:e119.
52. Beniash E, Hartgerink JD, Storrie H, et al. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater,2005; 1:387-397.
53. Galler KM, Cavender A, Yuwono V, et al. Self-assembling peptide amphiphile nanofibers as a scaffold for dental stem cells. Tissue Eng. Part A,2008; 14:2051-2058.
54. Narmoneva DA, Oni O, Sieminski AL, et al. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005; 26:4837-4846.
55. Kisiday J, Jin M, Kurz B, et al. Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division:implications for cartilage tissue repair. Proc Natl Acad Sci USA,2002; 99:9996-10001.
56. Horii A, Wang X, Gelain F, et al. Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3D migration. PLoS One,2007; 2:e190.
57. Misawa H, Kobayashi N, Soto-Gutierrez A, et al. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant,2006; 15:903-910.
58. Ellis-Behnke RG, Liang YX, You SW, et al. Nano neuro knitting:peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA,2006; 103:5054-5059.
59. Aggeli A, Bell M, Carrick LM, et al. pH as a trigger of peptide β-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc,2003; 125:9619-9628.
60. Kirkham J, Firth A, Vernals D, et al. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res,2007; 86:426-430.
61. Firth A, Aggeli A, Burke JL, et al. Biomimetic self-assembling peptides as injectable scaffolds for hard tissue engineering. Nanomed,2006; 1:189-199.
62. Bell CJ, Carrick LM, Katta J, et al. Self-assembling peptides as injectable lubricants for osteoarthritis. J Biomed Mater Res A,2006; 78:236-246.
63. Aggeli A, Bell M, Boden N, et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes. Nature,1997; 386:259-262.
64. Aggeli A, Nyrkova IA, Bell M, et al. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide P-sheet tapes, ribbons, fibrils, and fibres. Proc Natl Acad Sci USA,2001; 98:11857-11862.
65. Kretsinger JK, Haines LA, Ozbas B, et al. Cytocompatibility of self-assembled P-hairpin peptide hydrogel surfaces. Biomaterials,2005; 26:5177-5186.
66. Moutevelis E, Woolfson DN. A periodic table of coiled-coil protein structures. J Mol Biol,2009; 385:726-732.
67. Bromley EH, Sessions RB, Thomson AR, et al. Designed a-helical tectons for constructing multicomponent synthetic biological systems. J Am Chem Soc,2009; 131:928-930.
68. Papapostolou D, Smith AM, Atkins ED, et al. Engineering nanoscale order into a designed protein fiber. Proc Natl Acad Sci USA,2007; 104:10853-10858.
69. Gribbon C, Channon KJ, Zhang W, et al. Magic Wand:a single, designed peptide that assembles to stable, ordered a-helical fibers. Biochemistry,2008; 47:10365-10371.
70. Dong H, Paramonov SE, Hartgerink JD. Self-assembly of a-helical coil-coiled nanofibers. J Am Chem Soc,2008; 130:13691-13695.
71. Kotch FW, Raines RT. Self-assembly of synthetic collagen triple helices. Proc Natl Acad Sci, USA.2006; 103:3028-3033.
72. Yamazaki CM, Asada S, Kitagawa K, et al. Artificial collagen gels self-assembly of de novo designed peptides. Biopolymers 2008; 90:816-823.
73. Hammill JT, Miyake-Stoner S, Hazen JL, et al. Preparation of site-specifically labeled fluorinated proteins for 19F-NMR structural characterization. Nat Protoc,2007; 2:2601-2607.
74. Kuliopulos A, Walsh CT. Production, purification and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc,1994; 116:4599-4607.
75. Reed DC, Barnard GC, Anderson EB, et al. Production and purification of self-assembling peptides in Ralstonia eutropha. Protein Expr Purif,2006; 46:179-188.
76. Sharpe S, Yau WM, Tycko R. Expression and purification of a recombinant peptide from the Alzheimer's β-amyloid protein for solid-state NMR. Protein Expr Purif,2005; 42:200-210.
77. van Hell AJ, Costa CI, Flesch FM, et al. Self-assembly of recombinant amphiphilic oligopeptides into vesicles. Biomacromolecules,2007; 8:2753-2761.
78. Hartmann BM, Kaar W, Falconer RJ, et al. Expression and purification of a nanostructure-forming peptide. J Biotechnol,2008; 135:85-91.
79. Riley JM, Aggeli A, Koopmans RJ, et al. Bioproduction and characterization of a pH responsive self-assembling peptide. Biotechnol Bioeng,2009; 103:241-251.
80. Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif,2005; 41:207-234.
81. Zhang F. Designer self-assembling peptides scaffold stimulates pre-osteoblast attachment, spreading and proliferation. J. Mater Sci Mater Med,2009;
82. Zhou M, Smith AM, Das AK, et al. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials,2009; 30:2523-2530.
83. Sieminski AL, Semino CE, Gong H, et al. Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J Biomed Mater Res A,2008; 87:494-504.
84. Dubois G, Segers VF, Bellamy V, et al. Self-assembling peptide nanofibers and skeletal myoblast transplantation in infracted myocardium. J Biomed Mater Res B, 2008; 87:222-228.
85. Shen SH. Multiple joined genes prevent product degradation in Escherichia coli. Proc Natl Acad Sci USA,1984; 81:4627-4631.
86. Kim JM, Jang SA, Yu BJ, et al. High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol,2008; 78:123-130.
2. Kwon BK, Fisher CG, Dvorak M F, et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine,2005; 30:3-13.
3. Fehlings MG, Baptiste DC. Current status of clinical trials for acute spinal cord injury. Injury,2005; 36:113-122.
4. Schmidt CE. Leach JB. Neural tissue engineering:strategies for repair and regeneration. Annu Rev Biomed Eng,2003; 5:293-341.
5. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
6. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
7. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
8. Gage FH. Mammalian neural stem cell. Science,2000; 287:1433-1438.
9. Heller DA, Garga V, Kelleher KJ, et al. Patterned networks of mouse hippocampal neurons on peptide-coated gold surfaces. Biomaterials,2005; 26:883-889.
10. Shaw D, Shoichet MS. Toward spinal cord injury repair strategies:peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J Craniofac Surg,2003; 14:308-316.
11. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science,2004,303:1352-1355
1. Kwon BK, Fisher CG, Dvorak M F, et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine,2005; 30:3-13.
2. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science,1992; 255:1707-1710.
3. Davis AA, Temple S. A self-renewing multipotential stem cells in embryonic rat cerebral cortex. Nature,1994; 372:263-266
4. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci,1997; 17(3):5046-5061.
5. Kallos MS, Behie LA, Vescovi AL. Extended serial passaging of mammalian neural stem cells in suspension bioreactors. Biotechnol Bioeng,1999,65:589-99.
6. Vescovi AL, Parati EA, Gritti A, et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transp lantable human neural stem cell lines by epigenetic stimulation. Exp Neurol,1999; 156:71-83.
7. Temple S. The development of neural stem cells. Nature,2001; 414:112-117.
8. Whittemore SR, Morassutti DJ, Waiters WM, et al. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp Cell Res,1999; 252:75-95.
9. Brent A, Samuel W. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science,1992; 255:1707-1710.
10. Qian X, Davis AA, Goderie SK et al. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron,1997; 18:81-93.
11. Ciccolini F Identification of two distinct types of multipotent neural precursors that appear sequentially during CNS development. Mol Cell Neuro,2001; 17:895-907.
12. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell,1990; 60:585-595.
13. Cheng L, Jin Z, Liu L, et al. Characterization and promoter analysis of t he mouse nestin gene. FEBS Lett,2004; 565:195-202.
14. Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organization. Histol Histopathol,2005; 20:665-671.
15. Cai J, Wu Y, Mirua T, et al. Properties of a fetal multipotent neural stem cell (NEP cell). Dev Biol,2002; 251:221-240.
1. Whitesides GM, Mathias JP, Seto CT. Molecular self-assembly and nanochemistry:a chemical strategy for the synthesis of nanostructures. Science,1991; 254:1312-1319.
2. Corinne LD. Estimating the Efficiency of Self-Assemblies. Journal of Supramolecular Chemistry,2001; 1:39-52.
3. Whitesides GM, Mathias JP, Seto CT. Molecular self-assembly and nanochemistry:a chemical strategy for the synthesis of nanostructures. Science,1991; 254:1312-1319.
4. Ghadiri MR, Granja JR, Milligan RA, et al. Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature,1993; 366:324-327.
5. Zhang S, Holmes T, Lockshin C, et al. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA,1993; 90:3334-3338.
6. Giorgio C, Patricia S, Ehud G. Peptide self-assembly at the nanoscale:a challenging target for computational and experimental biotechnology. Trends Biochem Sci,2007; 25:211-218.
7. Aggeli A, Bell M, Carrick LM, et al. pH as a trigger of peptide β-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc,2003; 125:9619-9628.
8. Kirkham J, Firth A, Vernals D, et al. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res,2007; 86:426-430.
9. Firth A, Aggeli A, Burke JL, et al. Biomimetic self-assembling peptides as injectable scaffolds for hard tissue engineering. Nanomed,2006; 1:189-199.
10. Bell CJ, Carrick LM, Katta J, et al. Self-assembling peptides as injectable lubricants for osteoarthritis. J Biomed Mater Res A,2006; 78:236-246.
11. Aggeli A, Bell M, Boden N, et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric (3-sheet tapes. Nature,1997; 386:259-262.
12. Aggeli A, Nyrkova IA, Bell M, et al. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide (3-sheet tapes, ribbons, fibrils, and fibres. Proc Natl Acad Sci USA,2001; 98:11857-11862.
13. Kretsinger JK, Haines LA, Ozbas B, et al. Cytocompatibility of self-assembled β-hairpin peptide hydrogel surfaces. Biomaterials,2005; 26:5177-5186.
14. Moutevelis E, Woolfson DN. A periodic table of coiled-coil protein structures. J Mol Biol,2009; 385:726-732.
15. Bromley EH, Sessions RB, Thomson AR, et al. Designed a-helical tectons for constructing multicomponent synthetic biological systems. J Am Chem Soc,2009; 131:928-930.
16. Papapostolou D, Smith AM, Atkins ED, et al. Engineering nanoscale order into a designed protein fiber. Proc Natl Acad Sci USA,2007; 104:10853-10858.
17. Gribbon C, Channon KJ, Zhang W, et al. Magic Wand:a single, designed peptide that assembles to stable, ordered a-helical fibers. Biochemistry,2008; 47:10365-10371.
18. Dong H, Paramonov SE, Hartgerink JD. Self-assembly of a-helical coil-coiled nanofibers. J Am Chem Soc,2008; 130:13691-13695.
19. Kotch FW, Raines RT. Self-assembly of synthetic collagen triple helices. Proc Natl Acad Sci, USA.2006; 103:3028-3033.
20. Holmes TC. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol,2002; 20:16-21.
21. Branden C, Tooze J. Introduction to protein structure.2nd ed. New York, NY:Garland Publishing; 1999.
22. Petsko GA, Ringe D. Protein structure and function. London, UK:New Science Press Ltd.; 2003.
23. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
24. Davis ME, Motion JP. Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 2005; 111:442-450.
25. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
26. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
27. Yokoi H, Kinoshita T, Zhang S. Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc Natl Acad Sci USA,2005; 102:8414-8419.
28. Genove E, Shen C, Zhang S, et al. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials,2005:26:3341-3351.
1. Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol,2005; 15:413-420.
2. Davis ME, Motion JP, Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 2005; 111:442-450.
3. Zhang S. Designer Self-Assembling Peptide Nanofiber Scaffolds for Study of 3-D Cell Biology and Beyond. Adv Cancer Res,2008; 99:335-362.
4. Struve J, Maher PC, Li YQ, et al. Disruption of the hyaluronan-based extracellularmatrix in spinal cord promotes astrocyte proliferation. Glia,2005; 52: 16-24.
5. Caplan MR, Schwartzfarb EM, Zhang S, et al. Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. Biomaterials, 2002; 23:219-227.
6. Genove E, Shen C, Zhang S, et al. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials,2005; 26:3341-3351.
7. Heller DA, Garga V, Kelleher KJ, et al. Patterned networks of mouse hippocampal neurons on peptide-coated gold surfaces. Biomaterials,2005; 26:883-889.
8. Shaw D, Shoichet MS. Toward spinal cord injury repair strategies:peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J Craniofac Surg,2003; 14:308-316.
9. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science,2004; 303:1352-1355.
10. Gage FH. Mammalian neural stem cell. Science,2000; 287:1433-1438.
11. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Experimental neurology,2001; 167:48-58.
12. Cao QL, Howard RM, Dennison JB, et al. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Experimental neurology,2002; 177:349-359.
13. Enzmann GU, Benton RL, Woock JP, et al. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Experimental neurology,2005; 195:293-304.
14. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Experimental neurology,2004; 189:33-44.
15. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental neurology,2003; 181:115-129.
16. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. Journal of neuroscience research,2006; 84:1669-1681.
17. Pfeifer K, Vroemen M, Blesch A, et-al. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. The European journal of neuroscience,2004; 20:1695-1704.
18. Vroemen M, Aigner L, Winkler J, et al. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. The European journal of neuroscience,2003; 18:743-751.
19. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America, 2006; 103:13174-13179.
20. Engesser-Cesar C, Anderson AJ, Basso DM, et al. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma,2005; 22:157-171.
21. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proceedings of the National Academy of Sciences of the United States of America,2005; 102:14069-14074.
22. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cell differentiation following transplantation into spinal cord injured mice:association with recovery of locomotor function. Neurol Res,2006; 28:474-481.
23. Wu P, Tarasenko YI, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nature neuroscience,2002; 5:1271-1278.
24. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. Journal of neuroscience research,2005; 80:182-190.
25. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. Journal of neuroscience research, 2007; 85:47-57.
26. Howard MJ, Gershon MD. Development of LBP110 expression by neural crest-derived enteric precursors:migration and differentiation potential in Is/Is mutant mice. J Neurobiol,1998; 35:341-354.
27. Chalazonitis A, Tennyson VM, Kibbey MC, et al. The alphal subunit of laminin-1 promotes the development of neurons by interacting with LBP110 expressed by neural crest-derived cells immunoselected from the fetal mouse gut. J Neurobiol,1997; 33:118-138.
1. National Spinal Cord Injury Statistical Center Fact Sheet. National Spinal Cord Injury Center, Jun.2006.
2. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull,1999; 49:377-391.
3. McGee AW, Strittmatter SM. The Nogo-66 receptor:focusing myelin inhibition of axon regeneration. Trends Neurosci,2003; 26:193-198.
4. Myckatyn TM, Mackinnon SE, McDonald JW. Stem cell transplantation and other novel techniques for promoting recovery from spinal cord injury. Transpl Immunol, 2004; 12:343-358.
5. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol,2007; 17:120-127.
6. Greitz D. Unraveling the riddle of syringomyelia. Neurosurgical review 2006; 29:251-263.
7. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Experimental neurology,2004; 187:266-278.
8. Wu S, Suzuki Y, Ejiri Y, et al. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. Journal of neuroscience research,2003; 72:343-351.
9. Fok-Seang J, Smith-Thomas LC, Meiners S et al. An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res,1995; 689:207-223.
10. Smith-Thomas LC, Stevens J, Fok-Seang J, Faissner A, Rogers JH, Fawcett JW. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci,1995; 108:1307-1315.
11. Jones LL, Sajed D, Tuszynski MH. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury:a balance of permissiveness and inhibition. J Neurosci 2003; 23:9276-9288.
12. Curinga GM, Snow DM, Mashburn C, et al. Mammalianproduced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J Neurochem.2007; 102:275-288.
13. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002; 417:941-944.
14. Kottis V, Thibault P, Mikol D, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002; 82:1566-1569.
15. Huber AB, Schwab ME. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biological chemistry 2000; 381:407-419.
16. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature,2000; 403:434-439.
17. Liu BP, Fournier A, GrandPre T, et al. Myelinassociated glycoprotein as a functional ligand for the Nogo-66 receptor. Science,2002; 297:1190-1193.
18. Li S, Kim JE, Budel S, Hampton TG, et al. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Molecular and cellular neurosciences,2005; 29:26-39.
19. Yang LJ, Lorenzini I, Vajn K, et al. Sialidase enhances spinal axon outgrowth in vivo. Proceedings of the National Academy of Sciences of the United States of America 2006; 103:11057-11062.
20. Apostolova I, Irintchev A, Schachner M. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci,2006; 26:7849-7859.
21. Becker CG, Becker T, Meyer RL, Schachner M. Tenascin-R inhibits the growth of optic fibers in vitro but is rapidly eliminated during nerve regeneration in the salamander Pleurodeles waltl. J Neurosci,1999; 19:813-827.
22. Willerth SM, Arendas KJ, Gottlieb DI, et al. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006; 27:5990-6003.
23. Levenberg S, Burdick JA, Kraehenbuehl T, et al. Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue engineering,2005; 11:506-512.
24. Levenberg S, Huang NF, Lavik E, et al Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proceedings of the National Academy of Sciences of the United States of America 2003; 100:12741-12746.
25. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2002; 99:3024-3029.
26. Nomura H, Tator CH, Shoichet MS. Bioengineered strategies for spinal cord repair. J Neurotrauma,2006; 23:496-507.
27. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12:1-21.
28. Elisseeff JH. Embryonic stem cells:potential for more impact. Trends in Biotechnology,2004; 22:155-156.
29. Polak JM, Bishop AE. Stem cells and tissue engineering:past, present, and future. Annals of the New York Academy of Sciences,2006; 1068:352-366.
30. Wobus AM, Holzhausen H, Jakel P, et al. Characterization of a pluripotent stem cell line derived from a mouse embryo. Experimental cell research,1984; 152:212-219.
31. Keirstead HS. Stem cell transplantation into the central nervous system and the control of differentiation. Journal of neuroscience research,2001; 63:233-236.
32. Lee H, Al Shamy G, Elkabetz Y, et al. Directed Differentiation And Transplantation of Human Embryonic Stem Cell Derived Motoneurons. Stem cells,2007; 25:1931-1939.
33. Bain G, Kitchens D, Yao M, et al. Embryonic stem cells express neuronal properties in vitro. Developmental biology,1995; 168:342-357.
34. Liu S, Qu Y, Stewart TJ, Howard MJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proceedings of the National Academy of Sciences of the United States of America, 2000; 97:6126-6131.
35. Brustle O, Jones KN, Learish RD, et al. New York, NY:1999. Embryonic stem cell-derived glial precursors:a source of myelinating transplants. Science,285: 754-756.
36. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature medicine,1999; 5:1410-1412.
37. Jendelova P, Herynek V, Urdzikova L, et al. Magneticresonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. Journal of neuroscience research 2004; 76:232-243.
38. Kitagawa A, Nakayama T, Takenaga M, et al. Lecithinized brainderived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo. Biochemical and biophysical research communications,2005; 328:1051-1057.
39. Hendricks WA, Pak ES, Owensby JP, et al. Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice. Molecular medicine,2006; 12:34-46.
40. Howard MJ, Liu S, Schottler F, et al. Transplantation of apoptosis-resistant embryonic stem cells into the injured rat spinal cord. Somatosensory & motor research,2005; 22:37-44.
41. Chen J, Bernreuther C, Dihne M, et al. Cell adhesion molecule 11-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma 2005,22:896-906.
42. Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia, 2005; 49:385-396.
43. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci,2005; 25:4694-4705.
44. Faulkner J, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol,2005; 15:131-142.
45. Cloutier F, Siegenthaler MM, Nistor G, et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regenerative medicine,2006; 1:469-479.
46. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Experimental neurology,2001; 167:48-58.
47. Cao QL, Howard RM, Dennison JB, et al. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Experimental neurology,2002; 177:349-359.
48. Enzmann GU, Benton RL, Woock JP, et al. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal a) cord. Experimental neurology,2005; 195:293-304.
49. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Experimental neurology,2004; 189:33-44.
50. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental neurology,2003; 181:115-129.
51. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. Journal of neuroscience research,2006; 84:1669-1681.
52. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America, 2006; 103:13174-13179.
53. Engesser-Cesar C, Anderson AJ, Basso DM, et al. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma,2005; 22:157-171.
54. Vroemen M, Aigner L, Winkler J, et al. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. The European journal of neuroscience,2003; 18:743-751.
55. Pfeifer K, Vroemen M, Blesch A, et-al. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. The European journal of neuroscience,2004; 20:1695-1704.
56. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proceedings of the National Academy of Sciences of the United States of America,2005; 102:14069-14074.
57. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cell differentiation following transplantation into spinal cord injured mice:association with recovery of locomotor function. Neurol Res,2006; 28:474-481.
58. Wu P, Tarasenko YI, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nature neuroscience,2002; 5:1271-1278.
59. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. Journal of neuroscience research,2005; 80:182-190.
60. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. Journal of neuroscience research, 2007; 85:47-57.
61. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of neuroscience research,2000; 61:364-370.
62. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental neurology,2000; 164:247-256.
63. Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochemical and biophysical research communications,2001; 282:148-152.
64. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences of the United States of America,2002; 99:2199-2204.
65. Bakshi A, Barshinger AL, Swanger SA, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion:a novel method for minimally invasive cell transplantation. J Neurotrauma,2006; 23:55-65.
66. Shi E, Kazui T, Jiang X, et al. Therapeutic benefit of intrathecal injection of marrow stromal cells on ischemia-injured spinal cord. The Annals of thoracic surgery,2007; 83:1484-1490.
67. Khalatbary AR, Tiraihi T. Localization of bone marrow stromal cells in injured spinal cord treated by intravenous route depends on the hemorrhagic lesions in traumatized spinal tissues. Neurol Res,2007; 29:21-26.
68. Vaquero J, Zurita M, Oya S, et al. Cell therapy using bone marrow stromal cells in chronic paraplegic rats:systemic or local administration? Neuroscience letters,2006; 398:129-134.
69. Zurita M, Vaquero J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats:functional and morphological outcome one year after transplantation. Neuroscience letters,2006; 402:51-56.
70. Himes BT, Neuhuber B, Coleman C, et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabilitation and neural repair,2006; 20:278-296.
71. Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Experimental neurology,2004; 190:17-31.
72. Yano S, Kuroda S, Shichinohe H, et al. Bone marrow stromal cell transplantation preserves gammaaminobutyric acid receptor function in the injured spinal cord. J Neurotrauma,2006; 23:1682-1692.
73. Isele NB, Lee HS, Landshamer S, et al. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochemistry international,2007; 50:243-250.
74. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Experimental neurology,2005; 191:344-360.
75. Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic spinal cord injury. Experimental neurology,2007; 203:8-21.
76. Pannucci C, Myckatyn TM, Mackinnon SE, et al. End-to-side nerve repair:Review of the literature. Restorative neurology and neuroscience,2007; 25:45-63.
77. Feron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain,2005; 128:2951-2960.
78. Current Protocols in Cell Biology. John Wiley & Sons; 1998.
79. Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma,2006; 23:453-467.
80. Beattie MS, Bresnahan JC, Komon J, et al. Endogenous repair after spinal cord contusion injuries in the rat. Experimental neurology,1997; 148:453-463.
81. Blakemore WF. Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature,1977; 266:68-69.
82. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science,1981; 214:931-933.
83. Xu XM, Guenard V, Kleitman N, et al. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. The Journal of comparative neurology,1995; 351:145-160.
84. Xu XM, Guenard V, Kleitman N, et al. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Experimental neurology,1995; 134:261-272.
85. Xu XM, Chen A, Guenard V, et al. Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. Journal of neurocytology,1997; 26:1-16.
86. Imaizumi T, Lankford KL, Kocsis JD. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res 2000; 854:70-78.
87. Pinzon A, Calancie B, Oudega M, et al. Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. Journal of neuroscience research,2001; 64:533-541.
88. Takami T, Oudega M, Bates ML, et al. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci,2002; 22:6670-6681.
89. Menei P, Montero-Menei C, Whittemore SR, et al. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. The European journal of neuroscience,1998; 10:607-621.
90. Tuszynski MH, Weidner N, McCormack M, et al. Grafts of genetically modified Schwann cells to the spinal cord:survival, axon growth, and myelination. Cell transplantation,1998; 7:187-196.
91. Hurtado A, Moon LD, Maquet V, et al. Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials,2006; 27:430-442.
92. Chau CH, Shum DK, Li H, et al. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. Faseb J,2004; 18:194-196.
93. Pearse DD, Pereira FC, Marcillo AE, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature medicine,2004; 10:610-616.
94. Ruitenberg MJ, Vukovic J, Sarich J, et al. Olfactory ensheathing cells:characteristics, genetic engineering, and therapeutic potential. J Neurotrauma,2006; 23:468-478.
95. Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science,1997; 277:2000-2002.
96. Li Y, Field PM, Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci,1998; 18:10514-10524.
97. Keyvan-Fouladi N, Raisman G, Li Y. Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci,2003; 23:9428-9434.
98. Ramon-Cueto A, Cordero MI, Santos-Benito FF, et al. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron,2000; 25:425-435.
99. Lu J, Feron F, Ho SM, et al. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res,2001; 889:344-357.
100.Garcia-Alias G, Lopez-Vales R, Fores J, et al. Acute transplantation of olfactoryensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. Journal ofneuroscience research,2004; 75:632-641.
101.Kato T, Honmou 0, Uede T, et al. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 2000; 30:209-218.
102.Verdu E, Garcia-Alias G, Fores J, et al. Olfactory ensheathing cells transplanted in lesioned spinal cord prevent loss of spinal cord parenchyma and promote functional recovery. Glia,2003; 42:275-286.
103.Plant GW, Christensen CL, Oudega M, et al. Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma,2003; 20:1-16.
104.Ruitenberg MJ, Plant GW, Hamers FP, et al. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia:effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci,2003; 23:7045-7058.
105.Ruitenberg MJ, Levison DB, Lee SV, et al. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain,2005; 128:839-853.
106.Cao L, Liu L, Chen ZY, et al. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain,2004; 127:535-549.
107.Grill R, Murai K, Blesch A, et al. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci,1997; 17:5560-5572.
108.Tuszynski MH, Grill R, Jones LL, et al. Spontaneous and augmented growth of axons in the primate spinal cord:effects of local injury and nerve growth factor-secreting cell grafts. The Journal of comparative neurology,2002; 449:88-101.
109.Tobias CA, Shumsky JS, Shibata M, et al. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Experimental neurology,2003; 184:97-113.
110.Shumsky JS, Tobias CA, Tumolo M, et al. Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Experimental neurology,2003; 184:114-130.
111.McTigue DM, Horner PJ, Stokes BT, et al. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci,1998; 18:5354-5365.
112.Blesch A, Tuszynski MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. The Journal of comparative neurology,2003; 467:403-417.
113.Blesch A, Yang H, Weidner N, et al. Axonal responses to cellularly delivered NT-4/5 after spinal cord injury. Molecular and cellular neurosciences,2004; 27:190-201.
114.Pizzi MA, Crowe MJ. Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats. J Neurotrauma,2006; 23:1750-1765.
115.Mahoney MJ, Anseth KS. Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials,2006; 27:2265-2274.
116.Mahoney MJ, Anseth KS. Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic PEG hydrogels. Journal of biomedical materials research,2007; 81:269-278.
117.Taylor SJ, McDonald JW 3rd, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release,2004; 98:281-294.
118.Taylor SJ, Rosenzweig ES, McDonald JW 3rd, et al. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release, 2006; 113:226-235.
119.Taylor SJ, Sakiyama-Elbert SE. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release,2006; 116:204-210.
120.Willerth SM, Faxel TE, Gottlieb DI, et al. The Effects of Soluble Growth Factors on Embryonic Stem Cell Differentiation Inside of Fibrin Scaffolds. Stem cells,2007; 25: 2235-2244.
121.Ma W, Fitzgerald W, Liu QY, et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Experimental neurology,2004; 190:276-288.
122.Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene therapy,2001; 8:954-960.
123.Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature,2007; 448:318-324.
124.Lowry NA, Temple S. Making human neurons from stem cells after spinal cord injury. PLoS medicine,2007; 4:e48.
1. Zhang S. Emerging biological materials through molecular self-assembly. Biotechnol Adv,2002; 20:321-339.
2. Mitraki A, van Raaij MJ. Folding of P-structured fibrous proteins and self-assembling peptides. Methods Mol Biol,2005; 300:125-140.
3. Kluge JA, Rabotyagova O, Leisk GG, et al. Spider silks and their applications. Trends Biotechnol,2008; 26:244-251.
4. Koster S, Evans HM, Wong JY, et al. An in situ study of collagen self-assembly processes. Biomacromolecules,2008; 9:199-207.
5. Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater,2008; 15:53-76.
6. Chen H, Clarkson BH, Sun K, et al. Self-assembly of synthetic hydroxyapatite nanorods into an enamel prism-like structure. J Colloid Interface Sci,2005; 288:97-103.
7. Merrifield RB. Solid phase peptide synthesis. Ⅰ. The synthesis of a tetrapeptide. J. Am Chem Soc,1963; 85:2149-2154.
8. Sato AK, Viswanathan M, Kent RB, et al. Therapeutic peptides:technological advances driving peptides into development. Curr Opin Biotechnol.2006; 17:638-642.
9. Morreale G, Lee EG, Jones DB, et al. Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide. Biotechnol. Bioeng,2004; 87:912-923.
10. Prockop DJ, Kivirikko KI. Collagens:molecular biology, diseases, and potentials for therapy. Annu Rev Biochem,1995; 64:403-434.
11. Gelse K, Poschl E, Aigner T, et al. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev,2003; 55:1531-1546.
12. Prockop DJ. Kivirikko KI, Tuderman L, et al. The biosynthesis of collagen and its disorders. N Engl J Med,1979; 301:13-23.
13. Miyahara M, Njieha FK, Prockop DJ et al. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen protineases. J Biol Chem,1982; 257:8442-8448.
14. Brodsky B. Collagens and gelatins. In:Fahnestock, SR.; Steinbiichel, A., editors. Biopolymers, Polyamide and Complex Proteinaceous Materials.2nd edn. Vol. Vol.8. Wiley-VCH; Verlag GmbH,2003. p.119-128.
15. Pachence JM. Collagen-based devices for soft tissue repair. J Biomed Mater Res,1996; 33:35-40.
16. Olsen D, Yang C, Bodo M, et al. Recombinant collagen and gelatine for drug delivery. Adv Drug Deliv, Rev.2003; 55:1547-1567.
17. Baez J. Olsen D, Polarek JW. Recombinant microbial systems for the production of human collagen and gelatine. Appl Microbiol Biotechnol,2005; 69:245-252.
18. Koide T, Watson R, Kind AJ, et al. Triple helical collagen-like peptides:engineering and applications in matrix biology. Connect Tissue Res,2005; 46:131-141.
19. John DC. Expression of an engineered form of recombinant procollagen in mouse milk. Nat Biotechnol,1999; 17:385-389.
20. Bulleid NJ. John DC, Kadler KE. Recombinant expression systems for the production of collagen. Biochem Soc Trans,2000; 28:350-353.
21. Majsterek I, McAdams E, Adachi E, et al. Prospects and limitations of the rational engineering of fibrillar collagens. Protein Sci,2003; 12:2063-2072.
22. Tomita M, Kitajima T, Yoshizato K. Formation of recombinant human procollagen I heterotrimers in a baculovirus expression system. J. Biochem.1997; 121:1061-1069.
23. Kitajima T, Terai H, Ito Y et al. A fusion protein of hepatocyte growth factor for immobilisation to collagen. Biomaterials,2007; 28:1989-1997.
24. Ruggiero F, Exposito JY, Bournat P, et al. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett,2000; 469:132-136.
25. Merle C, Perret S, Lacour T, et al. Hydroxylated human homotrimeric collagen I in Agrobacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett,2002; 515:114-118.
26. Stephan S, Sherratt MJ, Hodson N, et al. Expression and supramolecular assembly of recombinant al (Ⅷ) and a2 (Ⅷ) collagen homotrimers. J Biol Chem,2004; 279:21469-21477.
27. Pakkanen O, Hamalainen ER, Kivirikko KI, et al. Assembly of stable human type Ⅰ and Ⅲ collagen molecules from hydroxylated recombinant chains in the yeast Pichia pastoris. Effect of an engineered C-terminal oligomerization domain foldon. J Biol Chem,2003; 278:32478-32483.
28. Du C, Wang M, Liu J, et al. Improvement of thermostability of recombinant collagen-like protein by incorporating a foldon sequence. Appl. Microbiol. Biotechnol, 2008; 79:195-202.
29. Keeley FW. Elastin as a self-organising biomaterial:use of recombinantly expressed human elastin polypeptides as a model for investigations of structure and self-assembly of elastin. Philos Trans R Soc Lond B Biol Sci,2002; 357:185-189.
30. Bellingham CM, Woodhouse KA, Robson P, et al. Self-aggregation characteristics of recombinantly expressed human elastin polypeptides. Biochim Biophys Acta,2001; 1550:6-19.
31. Urry DW. Molecular machines:how motion and other functions of living organisms cans result from reversible chemical changes. Angew Chem Int Ed Engl,1993; 32:819-841.
32. Bellingham CM, Keeley FW. Self-ordered polymerisation of elastin-based biomaterials. Curr Opin Solid State Mater Sci,2004; 8:135-139.
33. Daamen WF. Hafmans T, Veerkamp JH et al. Comparison of five procedures for the purification of insoluble elastin. Biomaterials 2001; 22:1997-2005.
34. Daamen WF, Nillesen ST, Hafmans T, et al. Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 2005; 26:81-92.
35. Urry DW, Pattanaik A, Xu J, et al. Elastic protein-based polymers in soft tissue augmentation and generation. J Biomater Sci Polym Ed,1998; 9:1015-1048.
36. Betre H, Setton LA, Meyer DE, et al. Characterisation of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002; 3:910-916.
37. Ong SR, Trabbic-Carlson KA, Nettles DL, et al. Epitope tagging for tracking elastin-like polypeptides. Biomaterials,2006; 27:1930-1935.
38. Srokowski EM, Woodhouse KA. Development and characterization of novel cross-linked bioelastomeric materials. J Biomater Sci Polym Ed,2008; 19:785-799.
39. Nicol A, Gowda C, Urry DW et al. Elastic protein-based polymers as cell attachment matrices. J Vasc Surg,1991; 13:746-748.
40. Wagenseil JE, Mecham RP. New insights into elastic fibre assembly. Birth Defects Res C Embryo Today,2007; 81:229-240.
41. Li B, Daggett V. The molecular basis of the temperature and pH induced conformational transitions in elastin-based peptides. Biopolymers,2003; 68:121-129.
42. Urry DW. Characterisation of soluble peptides of elastin by physical techniques. Methods Enzymol,1982; 82:673-716.
43. Raucher D, Chilkoti A. Enahnced uptake of a thermally responsive polypeptide by tumour cells in response to its hyperthermia-mediated phase transition. Cancer Res, 2001; 61:7163-7170.
44. Li B, Alonso DO, Daggett V et al. The molecular basis for the inverse temperature transition of elastin. J Mol Biol,2001; 305:581-592.
45. Nicol A, Gowda DC, Urry DW et al. Cell adhesion and growth on synthetic elastomeric matrices containing Arg-Gly-Asp-Ser-3. J Biomed Mater Res,1992; 26:393-413.
46. McPherson DT, Morrow C, Minehan DS, et al. Production and purification of a recombinant elastomeric polypeptide, G-(VPGVG)19-VPGV, from Escherichia coli. Biotechnol Prog,1992:8:347-352.
47. McHale MK, Setton LA, Chilkoti A. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng, 2005; 11:1768-1779.
48. Woodhouse KA, Klement P, Chen V, et al. Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials,2004; 25:4543-4553.
49. Girotti A, Reguera J, Rodriguez-Cabello JC, et al. Design and bioproduction of a recombinant multi(bio)functional elastin-like protein polymer containing cell adhesion sequences for tissue engineering purposes. J Mater Sci Mater Med,2004; 15:479-484.
50. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high epitope density nanofibers. Science,2004; 303:1352-1355.
51. Gelain F, Bottai D, Vescovi A, et al. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS One 2006; 1:e119.
52. Beniash E, Hartgerink JD, Storrie H, et al. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater,2005; 1:387-397.
53. Galler KM, Cavender A, Yuwono V, et al. Self-assembling peptide amphiphile nanofibers as a scaffold for dental stem cells. Tissue Eng. Part A,2008; 14:2051-2058.
54. Narmoneva DA, Oni O, Sieminski AL, et al. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005; 26:4837-4846.
55. Kisiday J, Jin M, Kurz B, et al. Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division:implications for cartilage tissue repair. Proc Natl Acad Sci USA,2002; 99:9996-10001.
56. Horii A, Wang X, Gelain F, et al. Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3D migration. PLoS One,2007; 2:e190.
57. Misawa H, Kobayashi N, Soto-Gutierrez A, et al. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant,2006; 15:903-910.
58. Ellis-Behnke RG, Liang YX, You SW, et al. Nano neuro knitting:peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA,2006; 103:5054-5059.
59. Aggeli A, Bell M, Carrick LM, et al. pH as a trigger of peptide β-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc,2003; 125:9619-9628.
60. Kirkham J, Firth A, Vernals D, et al. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res,2007; 86:426-430.
61. Firth A, Aggeli A, Burke JL, et al. Biomimetic self-assembling peptides as injectable scaffolds for hard tissue engineering. Nanomed,2006; 1:189-199.
62. Bell CJ, Carrick LM, Katta J, et al. Self-assembling peptides as injectable lubricants for osteoarthritis. J Biomed Mater Res A,2006; 78:236-246.
63. Aggeli A, Bell M, Boden N, et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes. Nature,1997; 386:259-262.
64. Aggeli A, Nyrkova IA, Bell M, et al. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide P-sheet tapes, ribbons, fibrils, and fibres. Proc Natl Acad Sci USA,2001; 98:11857-11862.
65. Kretsinger JK, Haines LA, Ozbas B, et al. Cytocompatibility of self-assembled P-hairpin peptide hydrogel surfaces. Biomaterials,2005; 26:5177-5186.
66. Moutevelis E, Woolfson DN. A periodic table of coiled-coil protein structures. J Mol Biol,2009; 385:726-732.
67. Bromley EH, Sessions RB, Thomson AR, et al. Designed a-helical tectons for constructing multicomponent synthetic biological systems. J Am Chem Soc,2009; 131:928-930.
68. Papapostolou D, Smith AM, Atkins ED, et al. Engineering nanoscale order into a designed protein fiber. Proc Natl Acad Sci USA,2007; 104:10853-10858.
69. Gribbon C, Channon KJ, Zhang W, et al. Magic Wand:a single, designed peptide that assembles to stable, ordered a-helical fibers. Biochemistry,2008; 47:10365-10371.
70. Dong H, Paramonov SE, Hartgerink JD. Self-assembly of a-helical coil-coiled nanofibers. J Am Chem Soc,2008; 130:13691-13695.
71. Kotch FW, Raines RT. Self-assembly of synthetic collagen triple helices. Proc Natl Acad Sci, USA.2006; 103:3028-3033.
72. Yamazaki CM, Asada S, Kitagawa K, et al. Artificial collagen gels self-assembly of de novo designed peptides. Biopolymers 2008; 90:816-823.
73. Hammill JT, Miyake-Stoner S, Hazen JL, et al. Preparation of site-specifically labeled fluorinated proteins for 19F-NMR structural characterization. Nat Protoc,2007; 2:2601-2607.
74. Kuliopulos A, Walsh CT. Production, purification and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc,1994; 116:4599-4607.
75. Reed DC, Barnard GC, Anderson EB, et al. Production and purification of self-assembling peptides in Ralstonia eutropha. Protein Expr Purif,2006; 46:179-188.
76. Sharpe S, Yau WM, Tycko R. Expression and purification of a recombinant peptide from the Alzheimer's β-amyloid protein for solid-state NMR. Protein Expr Purif,2005; 42:200-210.
77. van Hell AJ, Costa CI, Flesch FM, et al. Self-assembly of recombinant amphiphilic oligopeptides into vesicles. Biomacromolecules,2007; 8:2753-2761.
78. Hartmann BM, Kaar W, Falconer RJ, et al. Expression and purification of a nanostructure-forming peptide. J Biotechnol,2008; 135:85-91.
79. Riley JM, Aggeli A, Koopmans RJ, et al. Bioproduction and characterization of a pH responsive self-assembling peptide. Biotechnol Bioeng,2009; 103:241-251.
80. Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif,2005; 41:207-234.
81. Zhang F. Designer self-assembling peptides scaffold stimulates pre-osteoblast attachment, spreading and proliferation. J. Mater Sci Mater Med,2009;
82. Zhou M, Smith AM, Das AK, et al. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials,2009; 30:2523-2530.
83. Sieminski AL, Semino CE, Gong H, et al. Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J Biomed Mater Res A,2008; 87:494-504.
84. Dubois G, Segers VF, Bellamy V, et al. Self-assembling peptide nanofibers and skeletal myoblast transplantation in infracted myocardium. J Biomed Mater Res B, 2008; 87:222-228.
85. Shen SH. Multiple joined genes prevent product degradation in Escherichia coli. Proc Natl Acad Sci USA,1984; 81:4627-4631.
86. Kim JM, Jang SA, Yu BJ, et al. High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol,2008; 78:123-130.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |